| Xeloda® | |
| Brand Name: | Xeloda® |
| Active Ingredient: | capecitabine |
| Strength(s): | 150mg and 500mg |
| Dosage Form(s): | Tablets |
| Company Name: | Roche Laboratories, Inc. |
| Availability: | Prescription only |
| *Date Approved by FDA: | April 30, 1998 |
| *Approval by FDA does not mean that the drug is available for consumers at this time. | |
| What is Xeloda used for? Xeloda is used to treat breast cancer that
has spread to other parts of the body and does not respond to certain other chemotherapy
treatment. At this time it is not known whether Xeloda will improve symptoms, keep the disease from getting worse, or help patients live longer. Who should not take Xeloda?
Special Warnings with Xeloda:
General Precautions with Xeloda: Xeloda can cause tingling, numbness, pain, swelling, or redness in the palms of your hands or soles of your feet (hand and foot syndrome). Stop taking Xeloda and contact your doctor if you have signs of this syndrome. Your doctor may want to decrease your dose or stop your treatment with Xeloda. What are some possible side effects of Xeloda? (This is NOT a complete list of side effects reported with Xeloda. Your health care provider can discuss with you a more complete list of side effects.)
For more detailed information about Xeloda, ask your health care provider. Link to Xeloda's approved label and patient information Updated: 11/22/99 |